Magnetic resonance assessment of hypertrophic and pseudo-hypertrophic changes in lower leg muscles of boys with duchenne muscular dystrophy and their relationship to functional measurements

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Vohra, Ravneet S ^a   Lott, Donovan ^a   Mathur, Sunita ^a   Senesac, Claudia ^a   Deol, Jasjit ^a   Germain, Sean ^a   Bendixen, Roxanna ^a   Forbes, Sean C ^a   Sweeney, H Lee ^b   Walter, Glenn A ^a   Vandenborne, Krista ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; BODY HEIGHT; BODY SURFACE; BROOKE LOWER EXTREMITY SCORE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DUCHENNE MUSCULAR DYSTROPHY; EXTENSOR DIGITORUM LONGUS MUSCLE; FUNCTIONAL ASSESSMENT; GASTROCNEMIUS MUSCLE; HUMAN; LEG MUSCLE; MALE; MUSCLE HYPERTROPHY; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; PERONEUS MUSCLE; SCORING SYSTEM; SOLEUS MUSCLE; TIBIALIS ANTERIOR MUSCLE; TORQUE; HYPERTROPHY; LEG; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SKELETAL MUSCLE;

CHILD; CHILD, PRESCHOOL; HUMANS; HYPERTROPHY; LEG; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 84939153874     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128915     Document Type: Article

References (57)

1. Emery AE. Population frequencies of inherited neuromuscular diseases - a world survey. Neuromuscular disorders: NMD. 1991; 1(1):19-29. PMID: 1822774.
2. Mendell JR, Shilling C, Leslie ND, Flanigan KM, al-Dahhak R, Gastier-Foster J, et al. Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol. 2012; 71(3):304-13. doi: 10.1002/ana.23528 PMID: 22451200.
3. Hoffman EP, Brown RH Jr., Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987; 51(6):919-28. PMID: 3319190.
4. Baiardini I, Minetti C, Bonifacino S, Porcu A, Klersy C, Petralia P, et al. Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. Journal of child neurology. 2011; 26(6):707-13. Epub 2011/04/13. doi: 10.1177/0883073810389043 PMID: 21482750.
5. Bray P, Bundy AC, Ryan MM, North KN, Everett A. Health-related quality of life in boys with Duchenne muscular dystrophy: agreement between parents and their sons. Journal of child neurology. 2010; 25(10):1188-94. Epub 2010/02/25. doi: 10.1177/0883073809357624 PMID: 20179004.
6. Bendixen RM, Senesac C, Lott DJ, Vandenborne K. Participation and quality of life in children with Duchenne muscular dystrophy using the International Classification of Functioning, Disability, and Health. Health and quality of life outcomes. 2012; 10:43. Epub 2012/05/02. doi: 10.1186/1477-7525-10-43 PMID: 22545870; PubMed Central PMCID: PMC3358238.
7. McDouall RM, Dunn MJ, Dubowitz V. Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy. Journal of the neurological sciences. 1990; 99(2-3):199-217. Epub 1990/11/01. PMID: 1982294.
8. Desguerre I, Christov C, Mayer M, Zeller R, Becane HM, Bastuji-Garin S, et al. Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up. PloS one. 2009; 4(2):e4347. doi: 10.1371/journal.pone.0004347 PMID: 19194511; PubMed Central PMCID: PMC2633042.
9. Humbertclaude V, Hamroun D, Bezzou K, Berard C, Boespflug-Tanguy O, Bommelaer C, et al. Motor and respiratory heterogeneity in Duchenne patients: implication for clinical trials. European journal of paediatric neurology: EJPN: official journal of the European Paediatric Neurology Society. 2012; 16(2):149-60. doi: 10.1016/j.ejpn.2011.07.001 PMID: 21920787.
10. Deconinck N, Dan B. Pathophysiology of duchenne muscular dystrophy: current hypotheses. Pediatric neurology. 2007; 36(1):1-7. Epub 2006/12/13. doi: 10.1016/j.pediatrneurol.2006.09.016 PMID: 17162189.
11. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature. 1991; 352(6335):536-9. doi: 10.1038/352536a0 PMID: 1865908.
12. Bulfield G, Siller WG, Wight PAL, Moore KJ. X-CHROMOSOME-LINKED MUSCULAR-DYSTROPHY (MDX) IN THE MOUSE. Proceedings of the National Academy of Sciences of the United States of America-Biological Sciences. 1984; 81(4):1189-92. doi: 10.1073/pnas.81.4.1189. WOS: A1984SH73800045. PMID: 6583703
13. Gillis JM. Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse. Journal of Muscle Research and Cell Motility. 1999; 20(7):605-25. doi: 10.1023/a:1005545325254. WOS:000083716800001. PMID: 10672510
14. Gaschen FP, Hoffman EP, Gorospe JR, Uhl EW, Senior DF, Cardinet GH 3rd, et al. Dystrophin deficiency causes lethal muscle hypertrophy in cats. J Neurol Sci. 1992; 110(1-2):149-59. PMID: 1506854.
15. Carpenter JL, Hoffman EP, Romanul FC, Kunkel LM, Rosales RK, Ma NS, et al. Feline muscular dystrophy with dystrophin deficiency. The American journal of pathology. 1989; 135(5):909-19. PMID: 2683799; PubMed Central PMCID: PMC1880103.
16. Kornegay JN, Tuler SM, Miller DM, Levesque DC. Muscular dystrophy in a litter of golden retriever dogs. Muscle Nerve. 1988; 11(10):1056-64. doi: 10.1002/mus.880111008 PMID: 3185600.
17. Cooper BJ, Winand NJ, Stedman H, Valentine BA, Hoffman EP, Kunkel LM, et al. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature. 1988; 334(6178):154-6. doi: 10.1038/334154a0 PMID: 3290691.
18. Kim HK, Laor T, Horn PS, Racadio JM, Wong B, Dardzinski BJ. T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. Radiology. 2010; 255(3):899-908. Epub 2010/05/27. doi: 10.1148/radiol.10091547 PMID: 20501727.
19. Marden FA, Connolly AM, Siegel MJ, Rubin DA. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging. Skeletal radiology. 2005; 34(3):140-8. Epub 2004/11/13. doi: 10.1007/s00256-004-0825-3 PMID: 15538561.
20. Mathur S, Lott DJ, Senesac C, Germain SA, Vohra RS, Sweeney HL, et al. Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy. Archives of physical medicine and rehabilitation. 2010; 91(7):1051-8. Epub 2010/07/06. doi: 10.1016/j.apmr.2010.03.024 PMID: 20599043.
21. Wren TA, Bluml S, Tseng-Ong L, Gilsanz V. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR American journal of roentgenology. 2008; 190(1):W8-12. Epub 2007/12/21. doi: 10.2214/AJR.07.2732 PMID: 18094282.
22. Kinali M, Arechavala-Gomeza V, Cirak S, Glover A, Guglieri M, Feng L, et al. Muscle histology vs MRI in Duchenne muscular dystrophy. Neurology. 2011; 76(4):346-53. Epub 2011/01/26. doi: 10.1212/WNL.0b013e318208811f PMID: 21263136; PubMed Central PMCID: PMC3034418.
23. Torriani M, Townsend E, Thomas BJ, Bredella MA, Ghomi RH, Tseng BS. Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study. Skeletal radiology. 2012; 41(4):437-45. Epub 2011/07/30. doi: 10.1007/s00256-011-1240-1 PMID: 21800026.
24. Pradhan S, Mittal B. Infraspinatus muscle hypertrophy and wasting of axillary folds as the important signs in Duchenne muscular dystrophy. Clinical neurology and neurosurgery. 1995; 97(2):134-8. PMID: 7656486.
25. Richards P, Saywell WR, Heywood P. Pseudohypertrophy of the temporalis muscle in Xp21 muscular dystrophy. Developmental medicine and child neurology. 2000; 42(11):786-7. Epub 2000/12/05. PMID: 11104355.
26. Jones DA, Round JM, Edwards RH, Grindwood SR, Tofts PS. Size and composition of the calf and quadriceps muscles in Duchenne muscular dystrophy. A tomographic and histochemical study. Journal of the neurological sciences. 1983; 60(2):307-22. Epub 1983/08/01. PMID: 6886735.
27. Jansen M, van Alfen N, Nijhuis van der Sanden MW, van Dijk JP, Pillen S, de Groot IJ. Quantitative muscle ultrasound is a promising longitudinal follow-up tool in Duchenne muscular dystrophy. Neuromuscular disorders: NMD. 2012; 22(4):306-17. doi: 10.1016/j.nmd.2011.10.020 PMID: 22133654.
28. Rutkove SB, Geisbush TR, Mijailovic A, Shklyar I, Pasternak A, Visyak N, et al. Cross-sectional evaluation of electrical impedance myography and quantitative ultrasound for the assessment of Duchenne muscular dystrophy in a clinical trial setting. Pediatric neurology. 2014; 51(1):88-92. doi: 10.1016/j.pediatrneurol.2014.02.015 PMID: 24814059; PubMed Central PMCID: PMC4063877.
29. Arai Y, Osawa M, Fukuyama Y. Muscle CT scans in preclinical cases of Duchenne and Becker muscular dystrophy. Brain & development. 1995; 17(2):95-103. PMID: 7625556.
30. van der Graaf M, Tack CJ, de Haan JH, Klomp DW, Heerschap A. Magnetic resonance spectroscopy shows an inverse correlation between intramyocellular lipid content in human calf muscle and local glycogen synthesis rate. NMR in biomedicine. 2010; 23(2):133-41. Epub 2009/09/10. doi: 10.1002/nbm.1433 PMID: 19739109.
31. Kent-Braun JA, Ng AV, Young K. Skeletal muscle contractile and noncontractile components in young and older women and men. J Appl Physiol. 2000; 88(2):662-8. Epub 2000/02/05. PMID: 10658035.
32. Gray C, MacGillivray TJ, Eeley C, Stephens NA, Beggs I, Fearon KC, et al. Magnetic resonance imaging with k-means clustering objectively measures whole muscle volume compartments in sarcopenia/cancercachexia. Clin Nutr. 2011; 30(1):106-11. Epub 2010/08/24. doi: 10.1016/j.clnu.2010.07.012 PMID: 20727625.
33. Shah PK, Stevens JE, Gregory CM, Pathare NC, Jayaraman A, Bickel SC, et al. Lower-extremity muscle cross-sectional area after incomplete spinal cord injury. Arch Phys Med Rehabil. 2006; 87(6):772-8. doi: 10.1016/j.apmr.2006.02.028 PMID: 16731211.
34. Jayaraman A, Shah P, Gregory C, Bowden M, Stevens J, Bishop M, et al. Locomotor training and muscle function after incomplete spinal cord injury: case series. The journal of spinal cord medicine. 2008; 31(2):185-93. PMID: 18581666; PubMed Central PMCID: PMC2578797.
35. Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F. Muscle MRI in inherited neuromuscular disorders: past, present, and future. Journal of magnetic resonance imaging: JMRI. 2007; 25(2):433-40. Epub 2007/01/30. doi: 10.1002/jmri.20804 PMID: 17260395.
36. Wattjes MP, Kley RA, Fischer D. Neuromuscular imaging in inherited muscle diseases. European radiology. 2010; 20(10):2447-60. Epub 2010/04/28. doi: 10.1007/s00330-010-1799-2 PMID: 20422195; PubMed Central PMCID: PMC2940021.
37. Akima H, Lott D, Senesac C, Deol J, Germain S, Arpan I, et al. Relationships of thigh muscle contractile and non-contractile tissue with function, strength, and age in boys with Duchenne muscular dystrophy. Neuromuscular disorders: NMD. 2012; 22(1):16-25. Epub 2011/08/03. doi: 10.1016/j.nmd.2011.06.750 PMID: 21807516; PubMed Central PMCID: PMC3215817.
38. Forbes SC, Willcocks RJ, Triplett WT, Rooney WD, Lott DJ, Wang DJ, et al. Magnetic resonance imaging and spectroscopy assessment of lower extremity skeletal muscles in boys with Duchenne muscular dystrophy: a multicenter cross sectional study. PloS one. 2014; 9(9):e106435. doi: 10.1371/journal.pone.0106435 PMID: 25203313; PubMed Central PMCID: PMC4159278.
39. Gaeta M, Messina S, Mileto A, Vita GL, Ascenti G, Vinci S, et al. Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience. Skeletal radiology. 2012; 41(8):955-61. doi: 10.1007/s00256-011-1301-5 PMID: 22069033.
40. Beenakker EA, de Vries J, Fock JM, van Tol M, Brouwer OF, Maurits NM, et al. Quantitative assessment of calf circumference in Duchenne muscular dystrophy patients. Neuromuscular disorders: NMD. 2002; 12(7-8):639-42. Epub 2002/09/05. PMID: 12207931.
41. McDonald CM, Abresch RT, Carter GT, Fowler WM Jr, Johnson ER, Kilmer DD, et al. Profiles of neuromuscular diseases. Duchenne muscular dystrophy. American journal of physical medicine & rehabilitation / Associationof Academic Physiatrists. 1995; 74(5 Suppl):S70-92. Epub 1995/09/01. PMID: 7576424.
42. Brooke MH, Griggs RC, Mendell JR, Fenichel GM, Shumate JB, Pellegrino RJ. Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve. 1981; 4(3):186-97. doi: 10.1002/mus.880040304 PMID: 7017401.
43. Manini TM, Clark BC, Nalls MA, Goodpaster BH, Ploutz-Snyder LL, Harris TB. Reduced physical activity increases intermuscular adipose tissue in healthy young adults. The American journal of clinical nutrition. 2007; 85(2):377-84. Epub 2007/02/08. PMID: 17284732.
44. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity non-uniformity in MRI data. IEEE transactions on medical imaging. 1998; 17(1):87-97. doi: 10.1109/42.668698 PMID: 9617910.
45. Lamminen AE. Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. The British journal of radiology. 1990; 63(756):946-50. PMID: 2268764.
46. D'Angelo MG, Berti M, Piccinini L, Romei M, Guglieri M, Bonato S, et al. Gait pattern in Duchenne muscular dystrophy. Gait & posture. 2009; 29(1):36-41. doi: 10.1016/j.gaitpost.2008.06.002 PMID: 18656361.
47. Doglio L, Pavan E, Pernigotti I, Petralia P, Frigo C, Minetti C. Early signs of gait deviation in Duchenne muscular dystrophy. European journal of physical and rehabilitation medicine. 2011; 47(4):587-94. PMID: 21912365.
48. Gaudreault N, Gravel D, Nadeau S, Houde S, Gagnon D. Gait patterns comparison of children with Duchenne muscular dystrophy to those of control subjects considering the effect of gait velocity. Gait & posture. 2010; 32(3):342-7. doi: 10.1016/j.gaitpost.2010.06.003 PMID: 20599384.
49. Arpan I, Forbes SC, Lott DJ, Senesac CR, Daniels MJ, Triplett WT, et al. T(2) mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross-sectionalstudy of lower leg muscles in 5-15-year-old boys with Duchenne muscular dystrophy. NMR in biomedicine. 2013; 26(3):320-8. doi: 10.1002/nbm.2851 PMID: 23044995; PubMed Central PMCID: PMC3573223.
50. Cros D, Harnden P, Pellissier JF, Serratrice G. Muscle hypertrophy in Duchenne muscular dystrophy. A pathological and morphometric study. Journal of neurology. 1989; 236(1):43-7. Epub 1989/01/01. PMID: 2915226.
51. van Deutekom JC, Janson AA, Ginjaar IB, Frankhuizen WS, Aartsma-Rus A, Bremmer-Bout M, et al. Local dystrophin restoration with antisense oligonucleotide PRO051. The New England journal of medicine. 2007; 357(26):2677-86. Epub 2007/12/28. doi: 10.1056/NEJMoa073108 PMID: 18160687.
52. Reimers CD, Schlotter B, Eicke BM, Witt TN. Calf enlargement in neuromuscular diseases: a quantitative ultrasound study in 350 patients and review of the literature. J Neurol Sci. 1996; 143(1-2):46-56. PMID: 8981297.
53. Lynch GS, Hinkle RT, Chamberlain JS, Brooks SV, Faulkner JA. Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old. Journal of Physiology-London. 2001; 535(2):591-600. doi: 10.1111/j.1469-7793.2001.00591.x. WOS:000171024900023. PMID: 11533147
54. Sampaolesi M, Blot S, D'Antona G, Granger N, Tonlorenzi R, Innocenzi A, et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature. 2006; 444(7119):574-9. doi: 10.1038/nature05282 PMID: 17108972.
55. Krivickas LS, Ansved T, Suh D, Frontera WR. Contractile properties of single muscle fibers in myotonic dystrophy. Muscle Nerve. 2000; 23(4):529-37. PMID: 10716763.
56. Hasson CJ, Kent-Braun JA, Caldwell GE. Contractile and non-contractile tissue volume and distribution in ankle muscles of young and older adults. Journal of biomechanics. 2011; 44(12):2299-306. doi: 10.1016/j.jbiomech.2011.05.031 PMID: 21700287; PubMed Central PMCID: PMC3274550.
57. Hoffman EP, Connor EM. Orphan drug development in muscular dystrophy: update on two large clinical trials of dystrophin rescue therapies. Discovery medicine. 2013; 16(89):233-9. PMID: 24229740.